| Literature DB >> 11890310 |
Abstract
This paper establishes a framework for understanding the complex relationships between HIV-1 genotypic markers of resistance to antiretroviral drugs and clinical measures of disease progression. A new classification scheme based on the probabilities of how new patients will respond to antiretroviral therapy given the available data is proposed as a method for distinguishing among groups of viral sequences. This approach draws from existing cluster analysis, discriminant analysis, and recursive partitioning techniques and requires a model relating genotypic characteristics to phenotypic response. A data set of 2,746 sequences and the corresponding Indinavir 50% inhibitory concentrations are described and used for illustrative purposes.Entities:
Mesh:
Substances:
Year: 2002 PMID: 11890310 DOI: 10.1111/j.0006-341x.2002.00145.x
Source DB: PubMed Journal: Biometrics ISSN: 0006-341X Impact factor: 2.571